NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Werewolf Therapeutics Inc (NASDAQ: HOWL)

 
HOWL Technical Analysis
5
As on 8th Jul 2025 HOWL STOCK Price closed @ 1.06 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.73 & Strong Sell for SHORT-TERM with Stoploss of 6.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

HOWLSTOCK Price

Open 1.05 Change Price %
High 1.08 1 Day 0.01 0.95
Low 1.05 1 Week -0.08 -7.02
Close 1.06 1 Month -0.05 -4.50
Volume 364324 1 Year -3.41 -76.29
52 Week High 7.91 | 52 Week Low 0.63
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
LCID 2.30 9.00%
HCTI 0.02 0.00%
RLYB 0.51 50.00%
NVDA 160.00 1.11%
BTCS 5.91 111.07%
BTBT 3.74 7.47%
OPEN 0.73 15.87%
LMDX 0.02 0.00%
INTC 23.59 7.23%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
TBIO 0.30 500.00%
NBSTU 12.99 220.74%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
NDRA 8.30 139.88%
GLSPT 33.43 138.62%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
CTHR 0.21 -78.57%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
AXDX 0.03 -66.67%
TFFP 0.06 -62.50%
HEPA 0.12 -62.50%
 
 
HOWL
Daily Charts
HOWL
Intraday Charts
Whats New @
Bazaartrend
HOWL
Free Analysis
 
HOWL Important Levels Intraday
RESISTANCE1.12
RESISTANCE1.10
RESISTANCE1.09
RESISTANCE1.08
SUPPORT1.04
SUPPORT1.03
SUPPORT1.02
SUPPORT1.00
 
HOWL Forecast July 2025
4th UP Forecast8.73
3rd UP Forecast6.27
2nd UP Forecast4.75
1st UP Forecast3.23
1st DOWN Forecast-1.11
2nd DOWN Forecast-2.63
3rd DOWN Forecast-4.15
4th DOWN Forecast-6.61
 
HOWL Weekly Forecast
4th UP Forecast3.51
3rd UP Forecast2.72
2nd UP Forecast2.24
1st UP Forecast1.75
1st DOWN Forecast0.37
2nd DOWN Forecast-0.12
3rd DOWN Forecast-0.60
4th DOWN Forecast-1.39
 
HOWL Forecast2025
4th UP Forecast15.69
3rd UP Forecast11
2nd UP Forecast8.1
1st UP Forecast5.2
1st DOWN Forecast-3.08
2nd DOWN Forecast-5.98
3rd DOWN Forecast-8.88
4th DOWN Forecast-13.57
 
 
HOWL Other Details
Segment EQ
Market Capital 462034656.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
HOWL Address
HOWL
 
HOWL Latest News
 
Your Comments and Response on Werewolf Therapeutics Inc
 
HOWL Business Profile
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, with the help of its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates include WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company also develops WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts. Address: 1030 Massachusetts Avenue, Cambridge, MA, United States, 02138
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service